metricas
covid
Buscar en
Clínica e Investigación en Ginecología y Obstetricia
Toda la web
Inicio Clínica e Investigación en Ginecología y Obstetricia Cystosarcoma phyllodes maligno metastásico en muslo
Información de la revista
Vol. 29. Núm. 5.
Páginas 177-180 (enero 2002)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. 5.
Páginas 177-180 (enero 2002)
Acceso a texto completo
Cystosarcoma phyllodes maligno metastásico en muslo
Visitas
3734
J. Moreno, J. Díez, C. Osuna, P. Cañas, S. Luján, F.J. Rodríguez-Escudero
Unidad de Patología Mamaria. Oncología Ginecológica. Barakaldo. Bizkaia. España.
B. Eizaguirre*
* Departamento de Anatomía Patológica. Hospital de Cruces. Barakaldo. Bizkaia. España.
Este artículo ha recibido
Información del artículo
Summary

We describe the clinical features of a malignant Phyllodes tumour in a 41 year old patient, which me-tastasised in the soft tissue of the thigh. We correlate these findings with the histo-pathological criteria associated with the clinical course and metastatic behaviour of this tumour. Stromal overgrowth is the most important criteria for predicting the metastatic behaviour of a malignant Phyllodes tumour.

El Texto completo está disponible en PDF
Bibliografía
[1.]
Ch Zissis, N Apostolikas, A Konstantinidou, J Griniatsos, PP. Vassilopoulos.
The extent of surgery and prognosis with phyllodes tumor of the breast.
Breast Cancer Res Treat, 48 (1998), pp. 205-210
[2.]
E Rainville, KW. Hanley.
Metastatic cystosarcoma phyllodes.
A case report. Acta cytol, 37 (1993), pp. 555-558
[3.]
WHO..
Histological typing of breast tumors.
Tumori, 68 (1982), pp. 181-198
[4.]
M Reinfuss, J Mitus, K Duda, A Stelmach, J Rys, K. Smolak.
The treatment and prognosis of patients with phyllodes tumor of the breast.
An analysis of 170 cases. Cancer, 77 (1996), pp. 910-916
[5.]
G Cohn-Cedermark, LE Rutqvist, I Rosendahl, C. Silf-verswärd.
Prognostic factors in cystosarcoma phyllodes.
A clinico-pathologic study of 77 patients. Cancer, 68 (1991), pp. 2017-2022
[6.]
ED Staren, G Lynch, C Boyle, TR Witt, SD. Bines.
Malignant cystosarcoma phyllodes.
Am Surg, 60 (1994), pp. 583-585
[7.]
AA Mangi, BL Smith, MA Gadd, KK Tanabe, MJ Ott, WW. Souba.
Surgical management of phyllodes tumors.
Arch Surg, 134 (1999), pp. 487-493
[8.]
RE Hawwkins, JB Schofield, E Wiltshaw, C Fisher, JA. Mc-Kinna.
Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes.
Cancer, 69 (1992), pp. 2271-2275
[9.]
AW Chaney, A Pollack, MD Mcneese, GK Zagars, PW Pisters, RE Pollock, et al.
Primary treatment of cystosarcoma phyllodes of the breast.
Cancer, 89 (2000), pp. 1502-1511
[10.]
RE Hawkins, JB Schofield, C Fisher, E Wiltshaw, JA. McKinna.
The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes.
Cancer, 69 (1992), pp. 141-147
[11.]
WK De Roos, P Kaye, DM. Dent.
Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast.
Br J Sur, 86 (1999), pp. 396-399
[12.]
GI McGregor, MA Knowling, FA. Este.
Sarcoma and cysto-sarcoma phyllodes tumors of the breast.
A retrospective review of 58 cases. Am J Surg, 167 (1994), pp. 477-480
[13.]
DP Geisler, MJ Boyle, KF Malnar, JM McGee, MC Nolen, SM Fortner, et al.
Phyllodes tumors of the breast: a review of 32 cases.
Am Surg, 66 (2000), pp. 360-366
[14.]
MM Brentani, MA Nagai, CT Oshima, MM Pacheco, JC Goes, LB. Lemos.
Steroid receptors in cystosarcoma phyllodes.
Cancer Detect Prev, 5 (1982), pp. 211-219
[15.]
RJ. Barth.
Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors.
Breast Cancer Res Treat, 57 (1999), pp. 291-295
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos